Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planTo cover taxesOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 3 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025, Jan 2026 and Mar 2026.
- Largest single sale: $493K (894 shares) of Madrigal Pharmaceuticals, Inc. on Nov 21, 2025. Filing
- Last sale before this period: Mar 3, 2025.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Madrigal Pharmaceuticals, Inc. (MDGL) | Chief Commercial Officer | Nov 22, 2023 | Mar 6, 2026 |
Recent filings
The last 4 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Mar 6, 2026, Madrigal Pharmaceuticals, Inc.: sold 419 shares for $181K, to cover taxes. 1 filing: 1
- Mar 4, 2026, Madrigal Pharmaceuticals, Inc.: 3,989 shares granted. 1 filing: 1
- Jan 26, 2026, Madrigal Pharmaceuticals, Inc.: sold 910 shares for $449K, under a disclosed plan. 1 filing: 1
- Nov 21, 2025, Madrigal Pharmaceuticals, Inc.: sold 1,958 shares for $1.1M, under a disclosed plan. 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.